The latest oncology treatment & supportive care news
Sex differences identified in deadly brain tumours
For decades, scientists have recognised that more males get cancer and die of the disease…
Browsing: Treatment and Support
Patients now living a median 6.8 years after stage IV ALK positive lung cancer diagnosis
According to the National Cancer Institute, patients diagnosed with non-small cell lung cancer (NSCLC) between…
An errant editing enzyme promotes tumour suppressor loss and leukaemia propagation
Writing in the journal Cancer Cell, researchers at University of California San Diego School of Medicine…
Study reveals how solid stress from brain tumours causes neuronal loss, neurologic dysfunction
A Massachusetts General Hospital (MGH)-led research team has demonstrated, for the first time, how solid…
Hopkins researchers ID new biomarker for colorectal cancers
Johns Hopkins researchers have identified a protein involved in cell proliferation and the development of…
AYA World Cancer Congress Review by Ian Olver
Report on 3rd Annual Global Adolescent and Young Adult Cancer Congress, December 4-6th Sydney, Australia…
Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple-negative breast cancer
Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they…
SABCS 2018: Delaying adjuvant chemotherapy associated with worse outcomes for patients with triple-negative breast cancer
Patients with triple-negative breast cancer who delayed starting adjuvant chemotherapy for more than 30 days…
Black breast cancer patients have worse outcomes than whites, despite similar treatments
Black women with the most common form of early breast cancer had worse outcomes than…